Marrow Stromal Cells Differentiate Into Vasculature After Allogeneic Transplantation Into Ischemic Myocardium

Allogeneic transplantation of green MSCs can be safely used to elucidate the mechanisms of cell-based therapy. The benefits of this therapy appear mainly due to the angiogenesis, not the regeneration, of cardiac myocytes.